Cargando…
New Drugs Bringing New Challenges to AML: A Brief Review
The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel ther...
Autores principales: | Yeoh, Zhi Han, Bajel, Ashish, Wei, Andrew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537004/ https://www.ncbi.nlm.nih.gov/pubmed/34683144 http://dx.doi.org/10.3390/jpm11101003 |
Ejemplares similares
-
Corona virus disease bring a new challenge for the dentistry: A review
por: Vyas, Tarun, et al.
Publicado: (2020) -
Bringing New Methods to the Seed Proteomics Platform: Challenges and Perspectives
por: Smolikova, Galina, et al.
Publicado: (2020) -
Bringing New PET Drugs to Clinical Practice - A Regulatory Perspective
por: Hung, Joseph C.
Publicado: (2013) -
BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond
por: Wei, Andrew H., et al.
Publicado: (2023) -
Clinical Trials in Veterinary Medicine: A New Era Brings New Challenges
por: Oyama, M.A., et al.
Publicado: (2017)